Clin2
NCT06728605Possibly a fitNot yet recruiting

EECP therapy to protect heart after surgery

Coronary Heart Disease (CHD)Cardio-pulmonary BypassCongestive Heart Failure ChronicCardiogenic Shock Acute

Part of Heart & circulation clinical trials.

This trial tests if a non-invasive treatment called EECP (which uses leg cuffs to improve blood flow) can reduce harmful inflammation and help organs recover after heart surgery. It may benefit patients with heart conditions like angina, heart attack, or heart failure who are about to undergo surgery.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
400 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have a heart condition such as stable angina, unstable angina, heart attack, heart failure, or cardiogenic shock.
  • You are scheduled to have heart surgery during this hospital stay.
  • You agree to take part in the study and sign a consent form.
  • You do not have certain conditions like severe heart valve problems, active bleeding, or uncontrolled high blood pressure.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06707350Not yet recruiting
Could arm cuff before heart surgery protect your organs?

This study tests whether a simple arm blood pressure cuff technique (RIPC) given before heart surgery can reduce inflammation and protect your organs. It is for people at high risk of organ problems during or after surgery with a heart-lung machine.

Nanjing, Jiangsu
NCT04873687Recruiting
ECP treatment for stable angina while waiting for heart care

This trial studies whether ECP (a non-surgical treatment that improves blood flow to the heart) can reduce symptoms in people with stable angina who may need or are waiting for heart bypass surgery, or are being managed with medicines instead. It may help you feel better and need less urgent care—if you meet the study’s medical and personal requirements.

Bandung, West Java
NCT06227286Not yet recruiting
Enhanced counterpulsation after mitral valve repair (PAMPER)

This trial tests a treatment called enhanced external counterpulsation (EECP)—a noninvasive therapy that uses leg cuffs to improve blood flow—in people who have had a mitral valve repair procedure (TEER). It may help reduce the strain on your heart after the repair.

Guangzhou, Guangdong
NCT06608953Enrolling by invitation
EECP for artery stiffness in dialysis patients

This study tests whether a non‑invasive treatment called enhanced external counterpulsation (EECP) can help reduce stiffness in the arteries of people on chronic hemodialysis. It may improve heart health and make dialysis more effective.

Bangkok, Bangkok
NCT06336655Recruiting· Phase 2
Studying heart pump therapy for severe heart shock

This trial tests if unloading the heart during ECMO support helps patients recover better from cardiogenic shock. It compares different ways to reduce the heart's workload.

Salt Lake City, Utah
NCT05718622Recruiting
EECP for people with stable first stroke and blocked artery

This study looks at whether EECP (a non-surgical therapy that helps blood flow) improves outcomes in people who recently had their first ischemic stroke and have a narrowed or blocked artery. It also aims to predict who may benefit most based on health data.

Xi'an, Shaanxi

Hear when a new Cardio-pulmonary Bypass trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.